Over recent years the problems of monitoring, regulating, banning and criminalising the sale of new psychoactive drugs have been recognised. These substances may be every bit as dangerous as drugs that are already controlled substances under the Misuse of Drugs Act 1971 (“the MDA”). However, the rate at which new chemical formulations are devised means that a system of regulation such as the MDA, based on a specific identifiable substance, simply cannot keep up.
In the Queen’s Speech on 27 May 2015, the government announced that, “new legislation will… ban the new generation of psychoactive drugs.” The new regime seeks to classify substances not by their specific formulation (as under the MDA) but by their effect on the brain.